Answer
No, the safety and efficacy of Noxafil (posaconazole) 40 mg/ml oral suspension have not been established in children and adolescents under 18 years, and no dosing recommendation can be made.
Sources for this answer
- Noxafil 40mg/ml oral suspensionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.2 Posology and method of administration · Version 29Document updated
Sources checked